Ligand Pharmaceuticals Inc
NASDAQ:LGND

Watchlist Manager
Ligand Pharmaceuticals Inc Logo
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Watchlist
Price: 114.64 USD 0.61% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
Ligand Pharmaceuticals Inc?
Write Note

Intrinsic Value

The intrinsic value of one LGND stock under the Base Case scenario is 82.48 USD. Compared to the current market price of 114.64 USD, Ligand Pharmaceuticals Inc is Overvalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LGND Intrinsic Value
82.48 USD
Overvaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ligand Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
LGND
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for LGND cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about LGND?
Bearish
Neutral
Bullish

Fundamental Analysis

114.64 USD
+0.61%
+0.61%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Ligand Pharmaceuticals Inc
US
Biotechnology
Market Cap
2.2B USD
IPO
Nov 18, 1992
Employees
154
United States of America
Market Cap
2.2B USD
Industry
Biotechnology
IPO
Nov 18, 1992
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Ligand Pharmaceuticals Inc

Provide an overview of the primary business activities
of Ligand Pharmaceuticals Inc.

What unique competitive advantages
does Ligand Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Ligand Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Ligand Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Ligand Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ligand Pharmaceuticals Inc.

Provide P/S
for Ligand Pharmaceuticals Inc.

Provide P/E
for Ligand Pharmaceuticals Inc.

Provide P/OCF
for Ligand Pharmaceuticals Inc.

Provide P/FCFE
for Ligand Pharmaceuticals Inc.

Provide P/B
for Ligand Pharmaceuticals Inc.

Provide EV/S
for Ligand Pharmaceuticals Inc.

Provide EV/GP
for Ligand Pharmaceuticals Inc.

Provide EV/EBITDA
for Ligand Pharmaceuticals Inc.

Provide EV/EBIT
for Ligand Pharmaceuticals Inc.

Provide EV/OCF
for Ligand Pharmaceuticals Inc.

Provide EV/FCFF
for Ligand Pharmaceuticals Inc.

Provide EV/IC
for Ligand Pharmaceuticals Inc.

Show me price targets
for Ligand Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Ligand Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Ligand Pharmaceuticals Inc?

What are the Net Income projections
for Ligand Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Ligand Pharmaceuticals Inc?

What are the EPS projections
for Ligand Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Ligand Pharmaceuticals Inc?

What are the EBIT projections
for Ligand Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Ligand Pharmaceuticals Inc?

Compare the revenue forecasts
for Ligand Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ligand Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ligand Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ligand Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Ligand Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Ligand Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Ligand Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Ligand Pharmaceuticals Inc.

Provide ROE
for Ligand Pharmaceuticals Inc.

Provide ROA
for Ligand Pharmaceuticals Inc.

Provide ROIC
for Ligand Pharmaceuticals Inc.

Provide ROCE
for Ligand Pharmaceuticals Inc.

Provide Gross Margin
for Ligand Pharmaceuticals Inc.

Provide Operating Margin
for Ligand Pharmaceuticals Inc.

Provide Net Margin
for Ligand Pharmaceuticals Inc.

Provide FCF Margin
for Ligand Pharmaceuticals Inc.

Show all solvency ratios
for Ligand Pharmaceuticals Inc.

Provide D/E Ratio
for Ligand Pharmaceuticals Inc.

Provide D/A Ratio
for Ligand Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Ligand Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Ligand Pharmaceuticals Inc.

Provide Quick Ratio
for Ligand Pharmaceuticals Inc.

Provide Current Ratio
for Ligand Pharmaceuticals Inc.

Provide Cash Ratio
for Ligand Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Ligand Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Ligand Pharmaceuticals Inc?

What is the current Free Cash Flow
of Ligand Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ligand Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ligand Pharmaceuticals Inc

Current Assets 309.4m
Cash & Short-Term Investments 219.6m
Receivables 42.1m
Other Current Assets 47.6m
Non-Current Assets 645.5m
Long-Term Investments 13.2m
PP&E 25.2m
Intangibles 579.4m
Other Non-Current Assets 27.7m
Current Liabilities 24.8m
Accounts Payable 4.7m
Accrued Liabilities 16m
Other Current Liabilities 4m
Non-Current Liabilities 88.9m
Other Non-Current Liabilities 88.9m
Efficiency

Earnings Waterfall
Ligand Pharmaceuticals Inc

Revenue
152.4m USD
Cost of Revenue
-9.9m USD
Gross Profit
142.5m USD
Operating Expenses
-124.6m USD
Operating Income
18m USD
Other Expenses
27.3m USD
Net Income
45.2m USD

Free Cash Flow Analysis
Ligand Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

LGND Profitability Score
Profitability Due Diligence

Ligand Pharmaceuticals Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive Revenue Growth Forecast
Positive Net Income
53/100
Profitability
Score

Ligand Pharmaceuticals Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

LGND Solvency Score
Solvency Due Diligence

Ligand Pharmaceuticals Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
93/100
Solvency
Score

Ligand Pharmaceuticals Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LGND Price Targets Summary
Ligand Pharmaceuticals Inc

Wall Street analysts forecast LGND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LGND is 126.95 USD with a low forecast of 1.67 USD and a high forecast of 164.85 USD.

Lowest
Price Target
1.67 USD
99% Downside
Average
Price Target
126.95 USD
11% Upside
Highest
Price Target
164.85 USD
44% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LGND?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LGND is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LGND Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one LGND stock?

The intrinsic value of one LGND stock under the Base Case scenario is 82.48 USD.

Is LGND stock undervalued or overvalued?

Compared to the current market price of 114.64 USD, Ligand Pharmaceuticals Inc is Overvalued by 28%.

Back to Top